Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug

By Pam Belluck and Rebecca Robbins from NYT Health https://www.nytimes.com/2021/06/10/health/aduhelm-fda-resign-alzheimers.html?partner=IFTTT